Crake, R., Gasmi, I., Dehaye, J., Lardinois, F., Peiffer, R., Maloujahmoum, N., Agirman, F., KOOPMANSCH, B., D’Haene, N., Azurmendi Senar, O., Arsenijevic, T., Lambert, F., Peulen, O., Van Laethem, J.-L., & Bellahcene, A. (17 May 2023). Resistance to Gemcitabine in Pancreatic Cancer Is Connected to Methylglyoxal Stress and Heat Shock Response. Cells, 12 (10), 1414. doi:10.3390/cells12101414 |
LETE, C., FERNANDEZ CARAZO, R., MENTEN, C., BECKERS, P., KOOPMANSCH, B., FRANKE, S., DE PRIJCK, B., JAMAR, M., LAMBERT, F., & BOURS, V. (July 2021). A case of early-T-cell precursor acute lymphoblastic leukemia with e6a2 BCR-ABL1 fusion transcript [Poster presentation]. 13th European Cytogenomics Conference. |
Trimech, M., Letourneau, A., Missiaglia, E., DE PRIJCK, B., Nagy-Hulliger, M., SOMJA, J., Vivario, M., Gaulard, P., LAMBERT, F., Bisig, B., & de Leval, L. (2021). Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome. American Journal of Surgical Pathology, 45, 773-786. doi:10.1097/PAS.0000000000001646 |
Bellier, J., Nokin, M.-J., Caprasse, M., Tiamiou, A., Blomme, A., Scheijen, J. L., KOOPMANSCH, B., MacKay, G. M., Chiavarina, B., Costanza, B., Rademaker, G., Durieux, F., Agirman, F., Maloujahmoum, N., Cusumano, P. G., LOVINFOSSE, P., Leung, H. Y., LAMBERT, F., Bours, V., ... Bellahcene, A. (04 February 2020). Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab. Cell Reports, 30 (5), 1400-1416.e6. doi:10.1016/j.celrep.2020.01.012 |
FERNANDEZ CARAZO, R., KOOPMANSCH, B., PALMEIRA, L., CHARLOTEAUX, B., & LAMBERT, F. (2020). Hematopoietic Malignancies with Germline Predisposition Diagnosis with Filtered Whole Exome Sequencing and in silico Panel Analysis [Poster presentation]. European School of Haematology 2020. |
Delefortrie, Q., LAMBERT, F., Bulliard, G., Jurdan, M., Toffoli, S., Sartenaer, D., Theate, I., de Prophetis, S., Pranger, D., Konreich, A., & Mineur, P. (2017). A 54-year-old woman with a myeloid neoplasm associated with eosinophilia and t(5;12)(q33;p13)/PDFRFB rearrangement : case report and mini-review of the literature. Clinical Medical Reviews and Case Reports. doi:10.23937/2378-3656/1410170 |
KOOPMANSCH, B., LOPEZ Y CADENAS, M., Hennuy, B., & LAMBERT, F. (29 January 2016). Identification of a TPM3-PDGFRB fusion transcript and its chromosomal breakpoints by RNA-Seq in a case of Chronic Eosinophilic Leukemia [Poster presentation]. BHS General Annual Meeting 2016, United States - Texas. |
SAGOT, C., CHARLIER, H., KOOPMANSCH, B., & LAMBERT, F. (29 January 2016). Two cases of atypical CALR mutations in MPN patients [Poster presentation]. BHS General annual meeting 2016. |
DIDEBERG, V., SEGERS, K., KOOPMANSCH, B., LAMBERT, F., & Bours, V. (2015). PHARMACOGENOMIQUE ET MEDECINE PERSONNALISEE : VERS UN SCREENING SYSTEMATIQUE DE LA POPULATION ? Revue Médicale de Liège, 70 (5-6), 251-6. |
FOGUENNE, J., SIMUL, M., KEUTGENS, A., TASSIN, F., Bonnet, C., BEGUIN, Y., JAMAR, M., LAMBERT, F., & GOTHOT, A. (2015). Multiparameter flow cytometric analysis of composite lymphoma: case report of a mantle cell lymphoma associated with a B-cell chronic lymphocytic leukemia and an aberrant T cell subset. Belgian Journal of Hematology. |
JERUSALEM, G., COLLIGNON, J., Josse, C., SCHROEDER, H., RORIVE, A., FRERES, P., LAMBERT, F., KOOPMANSCH, B., PONCIN, A., & BOURS, V. (2015). Cancer du sein : de la thérapie ciblée à la médecine personnalisée. Revue Médicale de Liège, 70 (5-6), 269-276. |
CAERS, J., HAFRAOUI, K., KEUTGENS, A., CABERG, J.-H., LAMBERT, F., TASSIN, F., & BEGUIN, Y. (02 February 2014). Haematological and molecular responses in refractory anaemia with ring sideroblasts and thrombocytosis treated with lenalidomide. European Journal of Haematology, 92 (2), 179-180. doi:10.1111/ejh.12233 |
Bonnet, C., MENTEN, C., LAMBERT, F., Gothot, A., Baron, F., CAERS, J., HERENS, C., & Beguin, Y. (25 January 2013). Simultaneous diagnosis of CLL and CML in a single patient with evidence for two different cell clones [Poster presentation]. BHS, General Annual Meeting. |
Duhoux, F. P., Ameye, G., Lambot, V., HERENS, C., LAMBERT, F., Raynaud, S., Wlodarska, I., Michaux, L., Roche-Lestienne, C., Labis, E., Taviaux, S., Chapiro, E., Khac, F. N., Struski, S., Dobbelstein, S., Dastugue, N., Lippert, E., Speleman, F., Van Roy, N., ... Poirel, H. A. (2011). Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies. PLoS ONE, 6 (10), 26311. doi:10.1371/journal.pone.0026311 |
Robert, I., Aussems, M., Keutgens, A., Zhang-Shao, X., Hennuy, B., Viatour, P., Vanstraelen, G., Merville, M.-P., Chapelle, J.-P., de Leval, L., LAMBERT, F., Dejardin, E., Gothot, A., & Chariot, A. (02 April 2009). Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-κB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes. Oncogene, 28 (13), 1626-1638. doi:10.1038/onc.2009.6 |
Lambert, F., Heimann, P., Herens, C., Chariot, A., & Bours, V. (July 2007). Consultations in molecular diagnostics - A case of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia with a rare FIP1L1 breakpoint. Journal of Molecular Diagnostics, 9 (3), 414-419. doi:10.2353/jmoldx.2007.060196 |
Robe, P., Nguyen-Khac, M.-T., Lambert, F., Lechanteur, C., Jolois, O., Ernst-Gengoux, P., Rogister, B., & Bours, V. (January 2007). Sufasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas. International Journal of Oncology, 30 (1), 283-290. doi:10.3892/ijo.30.1.283 |
Leclercq, D., Boxus, E., De Brogniez, P., Wuidar, H., & Lambert, F. (1993). The taste approach : general implicit solutions in MCQs, confidence marking, open books exams and interactive testing. In D. Leclercq, Item banking, self-assessment and interactive testing : actes du NATO ARW Conférence de Liège, novembre 1992. Heidelberg, Germany: Springer Verlag. |